Belite Bio
Belite Bio Logo
About Belite Bio
Belite Bio Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for retinal degenerative eye diseases and age-related metabolic diseases with significant unmet medical needs. Its lead product candidate, Tinlarebant (LBS-008), is an oral therapy in late-stage clinical trials for Stargardt disease and geographic atrophy associated with dry age-related macular degeneration. The company is also developing LBS-009, an oral therapy targeting liver diseases such as non-alcoholic fatty liver disease and type 2 diabetes. Belite Bio leverages its proprietary RBP4 intellectual property portfolio to advance treatments for incurable blindness and metabolic disorders.
Address
12750 High Bluff Drive, Suite 475
San Diego, 92130
United States
Year founded
2018
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
